Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up

Details 詳細情報について

• CRID

  1360004231520056320

• DOI

  10.1007/s12185-013-1470-1

• ISSN

  18653774

  09255710

• Web Site

  http://link.springer.com/content/pdf/10.1007/s12185-013-1470-1.pdf

  http://link.springer.com/article/10.1007/s12185-013-1470-1/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s12185-013-1470-1

• Data Source

  • Crossref
  • KAKEN